Central Venous Surgical Catheter or Long Line, Management of A Baby With
Central Venous Surgical Catheter or Long Line, Management of A Baby With
Central Venous Surgical Catheter or Long Line, Management of A Baby With
Guideline G3
Title:
Version:
Ratification
Date:
Review Date:
Approval:
Author:
Job Title:
Consultation:
Guideline
Contact
Distribution:
Target
audience:
Patients to
whom this
applies:
Key Words:
Risk
Managed:
Evidence
used:
January 2013
November 2015
Nottingham Neonatal Service Clinical Guideline Meeting
Dr Colin Gilhooley, Dr Don Sharkey, (v1 Pru Fox)
Speciality Trainee (ST4) & Consultant Neonatologist (v1 Neonatal
Nurse)
Nottingham Neonatal Service Staff and Clinical Guideline Meeting.
Dr Stephen Wardle, Guideline Coordinator and Consultant
Neonatologist co/ Stephanie Tyrrell, Nottingham Neonatal Service
stephanie.tyrrell@nuh.nhs.uk
Nottingham Neonatal Service, Neonatal Intensive Care Units.
Staff of the Nottingham Neonatal Service.
Patients of the Nottingham Neonatal Service who fit the inclusion
criteria of the guideline below
Central line, catheter, long line, broviac.
Minimise infection risk, misplacement of line, reduce
risk of cardiac tamponade
The contemporary evidence base has been used to develop this
guideline. References to studies utilised in the preparation of this
guideline are given at its end.
Clinical guidelines are guidelines only. The interpretation and application of clinical
guidelines remain the responsibility of the individual clinician. If in doubt, contact a
senior colleague. Caution is advised when using guidelines after the review date.
This guideline has been registered with the Nottingham University Hospitals NHS
Trust.
This guideline does not include umbilical lines, for these please
refer to guidelines G1 and G5.
Guideline G3
Introduction/background
The two main types of central venous catheters discussed in this policy are:
Central line (Broviac - most frequently used line in neonates) made of radio-opaque silicone, it is
inserted as a surgical procedure through an incision in the upper chest or groin region, tunnelled
subcutaneously and positioned into the superior/inferior vena cava via a large vein. There is a cuff
attached to the catheter, which is positioned under the incision and helps secure the catheter
through fibrous tissue reaction, which occurs 1-2 weeks after insertion.
Silastic long line made of silastic, this fine bore catheter is aseptically inserted percutaneously into
a peripheral vein. It is advanced until the tip ideally lies in the superior or inferior vena cava.
However, insertion difficulties may result in the line tip being sited more peripherally. Nevertheless,
the line tip must be positioned in a large vein.
The term central venous catheters will be used in this guideline to describe both types of line
collectively. When the catheters are discussed separately, the name will be underlined to indicate
the difference.
1. Patient group/Indications
Central venous catheters are used for the administration of intravenous fluids, drugs and should
ideally always be used for parenteral nutrition administration.
Indications for use include:
major gastrointestinal problems and prolonged intolerance to enteral feeds
parenteral nutrition administration
where peripheral venous access is unsuccessful
requirement for drugs/infusions to be given centrally e.g. inotropes
occasionally for long term drug administration e.g. antifungal treatment
Central venous catheters are for long term use: the central line may be left in place indefinitely1, the
silastic long line should be considered for removal (and replacement if indicated) between 14 and
21 days after insertion. This guidance on the length of time a silastic long line may remain in situ
has been agreed by experienced-based consensus within the Nottingham Neonatal Service. It may
be necessary to leave the silastic long line in until the end of this time period, depending on the
babys clinical condition, especially in those babies with difficult intravenous (i.v.) access.
If possible, bolus and intermittent drug administration via both types of catheters should be avoided
as repeated manipulation of the lines are the main source by which bacteria are introduced.3 Bolus
administration also increases the risk of line rupture1,2,5,6. Peripheral venous access via standard
intravenous cannula should be the first choice in these situations. The exception to this rule is the
early care pathway for preterm infants <28 weeks gestation who have a UVC in when a double
lumen can be used to give drugs in order to preserve other veins (see Guidelines A8 and G5).
Central venous catheters ideally should only be used for bolus/intermittent drug
administration when peripheral vascular access is difficult. This should be discussed with
the NICU Consultant within 24 hours of commencing this strategy.
Blood products should not be administered via a silastic long line, as the fine bore catheter
will occlude.
Page 2 of 16
Guideline G3
Informed written consent in the medical notes is required for surgically placed central lines. The
information giving process should include a discussion of the problems of infection, thrombus
formation, line breakage and migration, pleural effusion and cardiac tamponade.
2.2
3.1 Personnel, Equipment and Insertion Procedures (silastic long line insertion only)
3.1.1 Personnel
Central line insertion
This is a sterile surgical procedure, undertaken within operating theatre conditions by those trained
to do so.
Silastic long line insertion
Silastic long line insertion is performed by a member of the medical team or an advanced neonatal
nurse practitioner who has had training and is competent to do so. A nurse or member of the
medical team who has knowledge of the infection control procedures followed for this procedure
should assist during the preparation for, and during the insertion of, the silastic long line. The
assistant should complete the Neonatal CVC Insertion Checklist (Appendix 5) with the
Page 3 of 16
Guideline G3
operator (person inserting the line) and file the completed form in the babys notes (see
Appendices 110 and 2).
3.1.2 Equipment (long line insertion only)
Dressing trolley (cleaned with disinfectant wipe)
Additional gauze pack
Sterile gown and towel pack
0.5% chlorhexidine
Steristrips
Long line (a Premicath can be used if baby is very Butterfly (24G line) or Breakaway needle (28G
small <1kg or venous access difficult).
premicath) both in the line packs
Tape measure (in line pack)
Anglepoise lamp or cold light if preferred (in sterile 0.9% saline vials (20mls)
glove)
Syringe pump with a pressure monitoring facility
Analgesia may also be required, for the non-ventilated baby this can be in the form of oral sucrose
unless contraindicated (see Guideline G6 Oral Sucrose on the NNU). In some cases it when
inserting difficult silastic long lines the use of short term muscle relaxation can help and if successful
avoid the need for a surgical line. This can only be considered in babies who are ventilated and
with no contraindications to the use of muscle relaxants. Care is needed to avoid changes with
ventilation when doing this especially for babies on minimal ventilation. If in doubt, discuss with a
senior colleague before using muscle relaxation.
3.1.3 Procedure
1. The baby must have respiratory (pulse oximetry) and cardiovascular monitoring (ECG) on when
inserting central venous catheters. This is essential as the baby will be covered in a sterile
dressing and if the line inadvertently enters the heart it could result in disturbances of heart
rate/rhythm.
2. The attending clinical and nursing team will discuss on the length of time the procedure will
normally take to avoid any excess stress for the baby. This will guide the number of attempts,
and by whom, based on how difficult/critical the line is.
3. An aseptic technique should be used2 and is undertaken by a member of the medical team or an
advanced neonatal nurse practitioner trained to do this (see self directed learning package on
aseptic non-touch technique for long line insertion). In particular, double gloving when preparing
the sterile field should occur in all instances. All equipment should be prepared using this
technique and the Neonatal CVC Insertion Checklist (Appendix 5) followed, completed and filed
in the patients notes (Appendix 1). Isolation screens should be placed around the patients
space to minimise the risk of interruptions, inadvertent desterilisation of equipment and privacy.
4. Identify the site of insertion. Suitable veins include:
-
5. Lines in the leg are associated with fewer complications, in particular infection11. Care must be
Page 4 of 16
Guideline G3
Guideline G3
4.
Clamping of both lines should be done using the products clamp only. The central line has
an area with a protective clamping sleeve with clear instructions on where to clamp the line.
The silastic long line should be clamped with care as the tubing can be easily damaged2.
All connections should be tightened and should use a Luer lock connection.
The infusion pumps used must have a pressure monitoring facility and the limit set at 50
mmHg above the lines running pressure on insertion. The line pressure, date and site of
insertion are recorded in the patients notes.
Line changes should be kept to a minimum1,2,3. All intravenous fluids in the line should, if
possible, be changed at the same time.
All lines and connections are cleaned by the assistant first and then again by the person
carrying out the changing procedure.
The change must be quick to ensure that a running infusion is maintained to ensure patency.
Page 6 of 16
5.
Guideline G3
Its removal is a surgical procedure that may occur on the unit (with appropriate training,
precautions and analgesia), or in the operating theatre environment typically for lines that
have been in for >2 weeks.
The tissue around the Surecuff may need incising and steristrips used to close the
wound.
The tip should be sent to microbiology for culture and sensitivity only if there are
concerns about possible infection.
Silastic long lines can stay in for a maximum of 28 days according to the guidance issued by the
manufacturer. However, local policy is that we aim to try and replace them before 21 days to
reduce the risks of complications, most notably infection. This often requires careful planning in
the days before to ensure any difficulties siting a new one does turn this into an urgent matter. If
the line is to remain in for >21 days this needs to be discussed with the NICU Consultant and
the reasons documented. Silastic long lines should be removed by a member of the medical
team, an advanced neonatal nurse practitioner or a critical care trained nurse competent to do
so making note of the following points:
6.1
Make a note of the length of line inserted and ensure the whole line is removed intact,
this must be documented.
The line should not be overstretched, as it may rupture and rebound into the vein. A
finger should be placed directly over the vein so that the line can be fixed immediately
should line rupture occur6.
If the silastic long line remains firmly attached then surgical removal is needed6.
Sustained gentle pressure should be applied following removal until homeostasis occurs
and a small dressing applied.
The line tip should be sent for culture and sensitivity only if there are concerns about
infection.
Specific issues
All medical and nursing staff should use an aseptic technique with gloves when undertaking any
procedure involving a central venous catheter.
If there is no alternative peripheral intravenous access, a central venous catheter may be used
Page 7 of 16
Guideline G3
for bolus drug administration and this strategy agreed with the duty NICU Consultant within 24
hours. This must be done aseptically and following the principles that are detailed in the policy
D12 Administration of intravenous drugs and fluids to neonates4.
All blood products may be infused through a central line but not through a silastic long line as
the lumen is too small.
If bolus drugs are to be administered the manipulation of the line should be kept to a minimum3.
The timing of drug administrations should be planned to occur simultaneously with fluid changes
when possible. A Y-connector and Luer lock should be added to the line and changed with the
line. This should be inserted as close to the patient as possible and removed if not required. All
drug containers should be used from new, handled and cleaned by the assistant and access
aseptically by the person carrying out the technique.
When using a central venous catheter, bolus injections must be slow and preferably using a 10
ml syringe1,2,5,6. Because of the necessity to give small accurate volumes of drugs, it may be
necessary to use a smaller syringe. The line should be flushed with intravenous saline 0.9%
using the larger syringe size initially to determine patency. (The central venous catheters are at
risk of rupturing if the infusion pressure exceeds 25 psi, which may happen using a 1 or 2 ml
syringe).
If the central venous catheter becomes blocked a member of the medical team, an advanced
neonatal nurse practitioner or critical care nurse can flush the line using an aseptic technique if
competent to do so. If a central line is blocked an attempt can be made to aspirate blood back
through the wider lumen before injecting 1-2 ml of 0.9% heparinised saline (1 IU/ml) using a
10ml syringe. This should be done with a gentle pressure. For a silastic long line, do not
aspirate back, as blood will occlude the narrow lumen, but flush with 1-2 ml of heparin in 0.9%
saline solution (1 IU/ml) using a 10 ml syringe. Do not flush excess heparin saline solution in,
just enough to remove the blockage.
Do not clean the tubing with an alcohol, acetone or spirit based cleaning solution as these can
damage the line1.
If a central line is not being used for continuous administration of fluids, it should be flushed
twice a week with a solution containing 10 units of heparin per ml. Refer to the manufacturers
instructions so that only the volume of the line is administered. Silastic long lines should always
have a minimum of 1ml/hr running through them to prevent blockage.
6.2
Central venous catheters should be taped to the patient to avoid any strain being placed on the
catheter and to prevent the tube becoming kinked or damaged.
During each daily review the medical notes must state:
1) The number of days the line has been in (only necessary for long lines)
2) If the dressing is clean and intact
3) There is no evidence of infection/inflammation or phlebitis at the line site.
Page 8 of 16
Guideline G3
These lines are often surgically placed in babies with very difficult IV access. It is
essential that these lines are cared for to minimise the risk of dislodgement especially
during the first 2 weeks of placement when they are at greater risk of coming out or
migrating. This requires firm anchorage of the dressing and line to prevent inadvertent
tugging of the line dislodging it.
It is recommended that a gauze and tape dressing is on for the first week until the cuff is
healed in, due to exit site exudate1. It should then be covered with an opaque
semipermeable sterile dressing.
A dressing change is recommended if there are signs of localised infection, or exudate
that is causing the dressing to lose its adhesiveness1. Two staff trained in the procedure
are required to change the dressing.
Otherwise, it is left in place until the line is
removed.
The site of entry and dressing should be examined daily for signs of infection,
inflammation or haemorrhage and documented in the medical and nursing notes.
If there are concerns that a line may have migrated or become dislodged then an X-ray
to check the position should be considered.
observations should include looking for signs of systemic infection.
General Trust guidance4 related to intravenous therapy asks for the use of anti-syphon valves for
syringe pump infusions. These are excluded in neonatal care currently, especially when pressure
monitoring is in place. From the information available, the pressure required to open the valve in
the first instance exceeds that achieved by neonates generally13,14.
7. Complications of central venous catheters
7.1
Infection
Central venous catheters are a portal of entry for infective pathogens which can cause significant
illness. In any baby with a central venous catheter in place the team should always be aware of line
associated sepsis especially if the babys condition deteriorates.
Central venous catheters are removed if septicaemia is proven and the baby has another
established route of venous access. However, in suspected sepsis the decision whether or not to
remove a central venous catheter is a clinical one and depends on many factors, including how
critical access is. In most cases, however, removal of a central venous line in suspected sepsis is
the best alternative and should be discussed with the duty NICU Consultant at the earliest
opportunity if the line is critical to the management of the baby.
For episodes of suspected line associated sepsis it is essential the attending team undertakes an
infection screen and starts appropriate antibiotics (see Guideline C1).
Page 9 of 16
7.2
Guideline G3
Misplacement/Malfunction
All central venous catheter lines will have radiographic confirmation of their position and placement
of the tip outside the cardiac silhouette. If after initial placement the silastic long line tip lies within
the cardiac silhouette and requires repositioning, a repeat X-ray to confirm final position (i.e. outside
cardiac silhouette) must be performed.
All central venous catheters should be observed for evidence of thrombosis, phlebitis or
extravasation. Important warning signs include swelling along the path of the catheter, erythema,
tenderness and increasing pressures on the infusion pumps. If these occur then immediate review
of the catheter is required and appropriate action taken. The attending team must decide if an X-ray
is required to confirm position, if antibiotics are required or if the catheter needs removing. If in
doubt this should be discussed with the NICU Consultant.
Occasionally the central venous catheter may split on the external portion. For central lines it may
be possible to repair this using the manufacturers repair kit. The surgical team should review the
line and decide if repair can occur and if so this should be performed by an appropriately trained
paediatric surgeon. If a silastic long line is damaged on the external limb it is advised to remove the
line and site a new one. If access is very difficult, it may be possible to replace the external arm of
the silastic long line using aseptic technique and opening a new line pack. This should be
discussed with the NICU Consultant.
7.3
The exact mechanism of cardiac tamponade is unclear. However, it is speculated that it results from
the placement or migration of the catheter tip into the right atrium. The trabeculae of the right atrium
may trap the tip of the catheter against the wall of the right atrium. The high pressure jet of
hypertonic parenteral nutrition then causes direct damage by inflammation and local necrosis. The
wall weakens and then perforates, leading to the accumulation of parenteral nutrition fluid in the
pericardial sac7.
7.3.1 Diagnosis and management of cardiac tamponade related to a central venous catheter
Although this is a rare complication (eleven cases were reported to the manufacturers over an eightyear period7), its severity required a high index of suspicion and it should be considered when a
baby with a central venous catheter becomes unwell and remains unwell despite routine
cardiorespiratory support. Signs of cardiac tamponade include tachycardia, poor perfusion and
soft/muffled sounding heart sounds. An urgent CXR comparing mediastinal size with recent films
may be useful if time permits. However, urgent ECHO looking for the tamponade is optimal.
As the pericardial fluid must be drained urgently, this should be discussed with the duty NICU
Consultant. To drain cardiac tamponade, a cannula (22 or 24 G) is inserted through the skin below
the xiphisternum, at an elevation of 30 degrees to the skin and advancing towards the left shoulder,
a syringe should be attached to remove all the fluid which should be like the infusate. The presence
of blood is unusual and probably suggests that the cannula has been inserted too far. The fluid
should be sent for microbiological and chemical assay9.
Attempts at insertion, duration of use, complications, consent rates and documentation require
frequent local audit.
Page 10 of 16
9.1
1.
2.
3.
4.
5.
9.2
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
Guideline G3
Page 11 of 16
Guideline G3
When printing patient notes copy please use the separate full page checklist
(Appendix 5) at the end of this guideline.
Page 12 of 16
Guideline G3
B)
C)
Example of silastic long line batch details sticker (B) and sterile pack tracking sticker (C) to
be placed with the above insertion sticker
Page 13 of 16
Guideline G3
Appendix 3.
Pressure/flow charts for A) the Premicath and B) Vygon long lines (adapted from Vygon
literature, August 1997)
A)
B)
Infusate = Water
Notes: Small neonatal/paediatric catheters will often require a higher back pressure or
operating pressure to enable forward flow of the infusate than larger adult catheters. Flow
rates are also affected by the catheter design and patient physiology:
Catheter design
Inner diameter of catheter
Patient related
Peripheral blood flow around catheter
Page 14 of 16
Guideline G3
Ensure that haemostasis has been attained and the site is as clean as blood under the
dressing may be a medium for the growth of skin commensals.
Secure the line in a loop without causing any strain on the tubing or coiling too tight as
these will create increased resistance or block the line using thin adhesive strips e.g.
Steristrips. The Steristrips must not fully encircle the limb
Place a small piece of gauze under the Vygon hub/ the insertion cannula for the
Premicath to prevent skin irritation/damage from the line.
Secure the blue/white hub and extension line to the patient to prevent any strain on the
silastic line.
Apply a transparent dressing once homeostasis is achieved. The steristrips, the hub
including its coloured and transparent parts and the line between the hub and insertion
site should be completely covered by the transparent dressing which must fully
adher to the limb but must not fully encircle the limb.
Page 15 of 16
Appendix 5
When printing patient notes copy
please use this checklist
Guideline G3
Place patient
sticker here
Babys Name:
Procedure:
Date:
Operator/s:
Observer:
Time:
Yes No
N/A
N/A
11
12
Completed checklist to be filed in the babys notes along with central line insertion stickers.
Page 16 of 16